Tag: JPIAMR

JPIAMR at the AMR Multi-Stakeholder Partnership Platform Plenary Assembly

Anna SundinNews and pressLeave a Comment on JPIAMR at the AMR Multi-Stakeholder Partnership Platform Plenary Assembly

JPIAMR took part in the 2nd Annual Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform (MSPP) that was held on 16 November in Jeddah, Saudi Arabia. The MSPP was established and facilitated by the Quadripartite organizations (FAO, UNEP, WHO and WOAH) in 2023 with the aim to catalyse a global movement for action against antimicrobial resistance (AMR) by fostering cooperation between a diverse range of stakeholders at all levels across the One Health spectrum.

The platform’s members shared progress and experiences since its inception and worked together on formulating concrete steps for implementation of the UNGA political declaration on AMR from September this year.

The annual assembly was held in conjunction with the Fourth High-level Ministerial Conference on AMR, which highlighted efforts and ambitions in infection prevention, diagnostics, and research and innovation. The importance of inclusivity of voices and perspectives and of securing sustainable financial resources to support all aspects of AMR mitigation was highlighted by panelists and speakers.

A few key points from JPIAMR’s perspective:

  • Basic research and innovation, and good scientists, are needed for sustainable access to antibiotics.
  • Repeated calls for comprehensive funding for research and innovation with a One Health perspective, from public and private sector representatives.
  • Research and knowledge valorisation in infection prevention, diagnostics, and optimal use of existing antibiotics are accessible solutions for immediate action.
  • To tackle AMR, we need to also recognize how it is situated in a system of poor basic health care, lack of clean water and sanitation, impact from conflicts and climate change, and the vulnerable balance between access to/excess of medications.
Call picture AMR Interventions call 2024.

New projects in the area of AMR interventions

Anna SundinNews and press

Thirteen projects involving 64 partners from 15 different countries have been recommended for funding within the JPIAMR 17th transnational call: Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments. The call was within the framework of the ERA‐NET JPIAMR-ACTION and the total funding amount is 17,2 M€.

The projects aim to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections, by focusing on the two topics of the call:

  • To design novel or improved interventions to prevent, mitigate and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance.
  • To improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

Read more about the projects.

Yellow wall and flowers

JPIAMR at ECCMID 2023

Anna SundinNews and press

The 33rd European Congress of Clinical Microbiology & Infectious Diseases, ECCMID, will take place in Copenhagen, Denmark, on 15-18 April 2023.

JPIAMR is co-organising the session Developing your funding application: from drug discovery to drug development on 16 April at 12:15-13:15 CEST.

Programme:

12:15 – Marc Lemonnier (Labege, France)

12:20 – JPIAMR funding calls and funding for academic research, Laura Marin (JPIAMR)

12:30 – Translating your research, Philip Packer (Innovate UK)

12:40 – Funding your innovation, Ursula Theuretzbacher (Center for Anti-Infective Agents, Austria)

12:50 – Q&A

13:15 – Wrap-up & End of session

Call picture for JPIAMR Diagnostics and Surveillance call 2023

Research call on AMR Diagnostics and surveillance now open

Anna SundinNews and press

The call Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance is now open. 

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 22 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

Partners working in eligible Least Developed Countries (LDCs) in in sub-Saharan Africa can be funded by the Swedish International Development Cooperation Agency (Sida).

The call will follow a two-step evaluation procedure and the deadline for pre-proposals is 7 March 2022. The full call text and the link to the online submission platform can be found on the call page: 

Call page “AMR diagnostics and surveillance 2023”

Webinar for applicants

A live webinar for applicants will be organised on the 24th of January 2023. This webinar will present the call and the partner search tool. Representatives from funders participating in the call will answer questions live.

Registration page Webinar for applicants

Shadows of people on a colourful background.

Six new networks in the area of diagnostics and surveillance

Anna SundinNews and pressLeave a Comment on Six new networks in the area of diagnostics and surveillance

Six networks have been recommended for funding within the JPIAMR 15th transnational call: Diagnostics and Surveillance Networks. The networks include 228 partners from 40 countries and the total funding amount is 300 000 € plus up to 100 000 € fort start-up and final joint workshops.

The networks assemble leading experts and stakeholders with an intent to facilitate the development, optimisation and use of diagnostic and surveillance tools, technologies and systems.

For the first time, a network focussed on antifungal resistance has been included.

Learn more about the networks

Northern lights

New projects in the area of therapeutics

Anna SundinNews and pressLeave a Comment on New projects in the area of therapeutics

Thirteen projects involving 72 partners from 15 different countries have been recommended for funding within the JPIAMR 14th transnational call: Disrupting drug Resistance Using Innovative Design. The call was within the framework of the ERA‐NET JPIAMRACTION and the total funding amount is 15,4 M€.

The projects aim to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

Learn more about the projects

Call picture for JPIAMR Diagnostics and Surveillance call 2023

Pre-announcement: Research call on AMR diagnostics and surveillance

Anna SundinNews and pressLeave a Comment on Pre-announcement: Research call on AMR diagnostics and surveillance

We are pleased to pre‐announce the transnational call Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance.

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 21 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

N.B New opening date! The call opens on 16 January 2023.

Read more on the call page

Reports from DESIGN OH AMR consultations available

Anna SundinNews and pressLeave a Comment on Reports from DESIGN OH AMR consultations available

In 2022, the Coordination and Support Action (CSA) DESIGN OH AMR has organised a series of stakeholder and expert consultations to collect input to the update of the research and innovation objectives within the JPIAMR Strategic Research and Innovation Agenda (SRIA). This serves in preparation for the Horizon Europe candidate One Health AMR Partnership.

The reports from the consultations are now available for download.

Illustration of the Globe with people and animals

Survey on funding instruments by the future OH AMR Partnership programme

Anna SundinNews and pressLeave a Comment on Survey on funding instruments by the future OH AMR Partnership programme

The JPIAMR has since its launch in 2011 coordinated 13 transnational joint calls till date supporting 99 projects and 38 networks with over 1300 researchers by investing 125 million Euros. In the framework of the CSA DESIGN, JPIAMR is preparing for the future One Health Antimicrobial Resistance (OH AMR) partnership programme including its portfolio for funding instruments. The OH AMR partnership programme will be a research and innovation (R&I) funding programme designed and launched jointly by the European Commission and member states. Using a combination of EU and national public R&I funding, this new programme will contribute to the European One Health Action Plan against AMR and the WHO Global Action Plan on AMR, both aiming to reduce the threat of antimicrobial resistance (AMR).

The aim of this survey is to gather feedback from the AMR research community to understand its views regarding gaps in the AMR funding landscape, and, the requirements for potential funding mechanisms with impact. These funding instruments could be used by JPIAMR member states and the European Commission in the future co-funded programme OH AMR partnership to support R&I and capacity building activities.

Link to survey: https://survey.vr.se/fundinginstrumentsOHAMR

The survey will close on the 26th September 2022 at 12.00 CEST

Pills on green background

Main achievements of Therapeutics research projects and networks

Anna SundinNews and pressLeave a Comment on Main achievements of Therapeutics research projects and networks

A report on the outputs, outcome and impact generated by the projects funded in the various JPIAMR transnational research project and network calls under the Therapeutics priority topic has been published.

This report has been prepared using information provided by the coordinators of the research projects and networks in the mid-term and the final term progress reports. The aim is to disseminate information about the outputs and the outcomes of the funded projects and networks to highlight the promising results of the funded research. Some highlights from the report on the main achievements of the Therapeutics research projects and networks and the impact generated are:

  • The JPIAMR discovery pipeline resulting from the funded research projects has a high level of diversity including direct acting molecules, potentiators or enablers, anti-virulence agents, repurposed agents, phage and nanobiotics.
  • Six new candidates/leads have been identified and five patents have been filed.
  • In addition to the peer-reviewed scientific articles in highly-recognised journals, the research projects and networks have also published white papers, roadmaps and position papers that can contribute to evidence-based policymaking.

Download the report: JPIAMR therapeutics discovery pipeline: Outputs, outcomes and impact of the funded projects and networks in the Therapeutics priority topic of the JPIAMR-SRIA (pdf 0,8 MB)